Review Article

Paragangliomas/Pheochromocytomas: Clinically Oriented Genetic Testing

Figure 1

Proposed algorithm for molecular genetic testing of paraganglioma/pheochromocytoma patients. The genes depicted in the boxes are most likely to account for the clinical phenotype and should be analyzed in the proposed order. Mutations in TMEM127, MAX, HIF2A, and SDHAF2 are extremely rare, so they should only be analyzed when patients are negative for the other gene mutations.
794187.fig.001